Back
Albemarle Vs. Doximity Industry Stock Comparison
Sell
38
ALB
Albemarle
Last Price:
$94.08
Seasonality Move:
2.26%
Buy
89
DOCS
Doximity
Last Price:
$55.50
Seasonality Move:
-0.09%
Sell
38
Albemarle (ALB)
is a Sell
Is Albemarle a Buy, Sell or Hold?
-
ALB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALB Stock Price Chart
DOCS Stock Price Chart
ALB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.1 | Sell |
Relative Strength Index (14 RSI): | 57.57 | Buy |
Chaikin Money Flow: | 374484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.64 - 97.26) | Buy |
Bollinger Bands (100): | (87.6 - 103.58) | Buy |
DOCS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 50.97 | Buy |
Chaikin Money Flow: | 31053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.85 - 56.57) | Sell |
Bollinger Bands (100): | (39.92 - 53.9) | Buy |
ALB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.87 | Buy |
20-day SMA: | 89.76 | Buy |
50-day SMA: | 98.71 | Sell |
200-day SMA: | 101.6 | Sell |
8-day EMA: | 92.97 | Buy |
20-day EMA: | 92.65 | Buy |
50-day EMA: | 95.27 | Buy |
200-day EMA: | 105.3 | Sell |
DOCS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.87 | Buy |
20-day SMA: | 54.6 | Sell |
50-day SMA: | 53.06 | Buy |
200-day SMA: | 37.32 | Buy |
8-day EMA: | 53.12 | Buy |
20-day EMA: | 53.6 | Buy |
50-day EMA: | 51.79 | Buy |
200-day EMA: | 41.14 | Buy |
Albemarle Earnings Growth & ALB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.39 per share, and an increase next year of $3.63 per share.
Doximity Earnings Growth & DOCS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.10 per share.
Albemarle Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Doximity Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |